# $krro Korro Bio sees analyst upgrades following a pivot to urea cycle disorders with its KRRO-121 program, after the failure of its KRRO-110 AATD trial. ### About $krro Korro Bio is a biotechnology company focused on developing RNA-editing therapeutics. ### Engagements: [-----] (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$krro/time-series/interactions.tsv) Current Value: [-----] Daily Average: [-----] [--] Month: [------] +107% [--] Months: [-------] +202% [--] Year: [---------] +37% 1-Year High: [-------] on 2025-11-13 1-Year Low: [--] on 2025-05-11 Engagements by network (24h): X: [-----] YouTube: [--] ### Mentions: [--] (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$krro/time-series/posts_active.tsv) Current Value: [--] Daily Average: [--] 1-Year High: [---] on 2025-11-13 1-Year Low: [--] on 2025-05-26 Mentions by network (24h): X: [--] YouTube: [--] ### Creators: [--] (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$krro/time-series/contributors_active.tsv) [--] unique social accounts have posts mentioning $krro in the last [--] hours which is up 67% from [--] in the previous [--] hours Daily Average: [--] 1-Year High: [---] on 2025-06-29 1-Year Low: [--] on 2025-05-26 The most influential creators that mention $krro in the last [--] hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@TheOptionsBull2](/creator/twitter/TheOptionsBull2) | [--] | [---] | [--] | [--] | | [@seedytx19](/creator/twitter/seedytx19) | [--] | [-----] | [--] | [--] | | [@Fredbenz0](/creator/twitter/Fredbenz0) | [--] | [-----] | [--] | [--] | | [@Iam__Mouni](/creator/twitter/Iam__Mouni) | [--] | [---] | [--] | [--] | | [@CHItraders](/creator/twitter/CHItraders) | [--] | [-----] | [--] | [--] | [View More](/list/creators/$krro/100) ### Top $krro Social Posts Top posts by engagements in the last [--] hours *Showing a maximum of [--] top social posts without a LunarCrush subscription.* "@zhaoweiasu Yes a few such claims have been made including by $sgmo and the Arc Institute. We'll see. $krro has also achieved 90% #RNAediting of alpha-1 by a year of hard optimization work" [X Link](https://x.com/RNAiAnalyst/status/2016650887628792027) [@RNAiAnalyst](/creator/x/RNAiAnalyst) 2026-01-28T23:13Z 21.1K followers, [---] engagements "Midday Fly By: AT&T reports Q4 beat Amazon cuts [-----] jobs $GLW $EXTR $SMG $EAT $LII $PDYN $LRN $NXT $RGNX $RR $LEA $GM $MGA $AI $TSLA $SFTBY $DB $V $KRRO $CRCL $PYPL $BJ $STX $TXN $T $SBUX $AMZN https://tinyurl.com/4wbjzy8f https://tinyurl.com/4wbjzy8f" [X Link](https://x.com/theflynews/status/2016558008197624095) [@theflynews](/creator/x/theflynews) 2026-01-28T17:04Z 28.9K followers, [----] engagements "Upgrades 1/28: $AMAT $CRCL $JNJ $KKR $KRRO $MCHP $NXT $SYF $TXN $UPS $UUUU $V . Downgrades 1/28: $ARRY $BBVA $BJ $BRO $CCBG $KOF $MLM $NUE $PAA $PAGP $PRAA $PYPL $RIO $ROP $WAL" [X Link](https://x.com/OpenOutcrier/status/2016510172605108291) [@OpenOutcrier](/creator/x/OpenOutcrier) 2026-01-28T13:54Z 80.1K followers, [----] engagements "$KRRO this one is $FREQ merger name As previously reported Oppenheimer upgraded Korro Bio to Outperform from Perform with a $22 price target. Following the failure of the KRRO-110 AATD program likely due to the LNP/delivery approach Korro's focus turns to urea cycle disorders caused by elevated ammonia levels and characterized by a high unmet need. KRRO-121 introduces a mutation via RNA editing leading to glutamine synthetase stabilization and consequently ammonia lowering. Provided that KRRO-121 is fundamentally different from KRRO-110 Oppenheimer believes the company's probability of" [X Link](https://x.com/zohmbastic/status/2016499315041006057) [@zohmbastic](/creator/x/zohmbastic) 2026-01-28T13:11Z [----] followers, [----] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
Korro Bio sees analyst upgrades following a pivot to urea cycle disorders with its KRRO-121 program, after the failure of its KRRO-110 AATD trial.
Korro Bio is a biotechnology company focused on developing RNA-editing therapeutics.
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Month: [------] +107%
[--] Months: [-------] +202%
[--] Year: [---------] +37%
1-Year High: [-------] on 2025-11-13
1-Year Low: [--] on 2025-05-11
Engagements by network (24h): X: [-----] YouTube: [--]
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
1-Year High: [---] on 2025-11-13
1-Year Low: [--] on 2025-05-26
Mentions by network (24h): X: [--] YouTube: [--]
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $krro in the last [--] hours which is up 67% from [--] in the previous [--] hours
Daily Average: [--]
1-Year High: [---] on 2025-06-29
1-Year Low: [--] on 2025-05-26
The most influential creators that mention $krro in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @TheOptionsBull2 | [--] | [---] | [--] | [--] |
| @seedytx19 | [--] | [-----] | [--] | [--] |
| @Fredbenz0 | [--] | [-----] | [--] | [--] |
| @Iam__Mouni | [--] | [---] | [--] | [--] |
| @CHItraders | [--] | [-----] | [--] | [--] |
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"@zhaoweiasu Yes a few such claims have been made including by $sgmo and the Arc Institute. We'll see. $krro has also achieved 90% #RNAediting of alpha-1 by a year of hard optimization work"
X Link @RNAiAnalyst 2026-01-28T23:13Z 21.1K followers, [---] engagements
"Midday Fly By: AT&T reports Q4 beat Amazon cuts [-----] jobs $GLW $EXTR $SMG $EAT $LII $PDYN $LRN $NXT $RGNX $RR $LEA $GM $MGA $AI $TSLA $SFTBY $DB $V $KRRO $CRCL $PYPL $BJ $STX $TXN $T $SBUX $AMZN https://tinyurl.com/4wbjzy8f https://tinyurl.com/4wbjzy8f"
X Link @theflynews 2026-01-28T17:04Z 28.9K followers, [----] engagements
"Upgrades 1/28: $AMAT $CRCL $JNJ $KKR $KRRO $MCHP $NXT $SYF $TXN $UPS $UUUU $V . Downgrades 1/28: $ARRY $BBVA $BJ $BRO $CCBG $KOF $MLM $NUE $PAA $PAGP $PRAA $PYPL $RIO $ROP $WAL"
X Link @OpenOutcrier 2026-01-28T13:54Z 80.1K followers, [----] engagements
"$KRRO this one is $FREQ merger name As previously reported Oppenheimer upgraded Korro Bio to Outperform from Perform with a $22 price target. Following the failure of the KRRO-110 AATD program likely due to the LNP/delivery approach Korro's focus turns to urea cycle disorders caused by elevated ammonia levels and characterized by a high unmet need. KRRO-121 introduces a mutation via RNA editing leading to glutamine synthetase stabilization and consequently ammonia lowering. Provided that KRRO-121 is fundamentally different from KRRO-110 Oppenheimer believes the company's probability of"
X Link @zohmbastic 2026-01-28T13:11Z [----] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$krro